Discontinued — last reported Q1 '20
Current Liabilities
Restructuring Reserve
Gilead Sciences Restructuring Reserve decreased by 43.5% to $52.00M in Q3 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ4 2015
Last reportedQ1 2020
How to read this metric
An increase suggests active cost-cutting or strategic realignment, which may lead to future margin expansion but indicates current operational friction.
Detailed definition
This liability captures the estimated costs associated with formal restructuring plans, such as severance packages, faci...
Peer comparison
Common in large financial institutions undergoing digital transformation or cost-rationalization programs.
Metric ID:
restructuring_reserveHistorical Data
3 periods
| Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|
| Value | $138.00M | $92.00M | $52.00M |
| QoQ Change | — | -33.3% | -43.5% |
Range$52.00M – $138.00M
Current Streak2+ quarters decline
Restructuring Reserve at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's restructuring reserve?
- Gilead Sciences (GILD) reported restructuring reserve of $52.00M in Q3 2025.
- What does restructuring reserve mean?
- The estimated cost set aside for future business reorganization and downsizing activities.